KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Operating Margin (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Operating Margin for 17 consecutive years, with 19.64% as the latest value for Q4 2025.

  • Quarterly Operating Margin rose 223.0% to 19.64% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 18.17% through Dec 2025, up 190.0% year-over-year, with the annual reading at 18.17% for FY2025, 190.0% up from the prior year.
  • Operating Margin hit 19.64% in Q4 2025 for Abbott Laboratories, up from 18.09% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 24.48% in Q1 2022 to a low of 12.92% in Q4 2022.
  • Historically, Operating Margin has averaged 17.76% across 5 years, with a median of 17.4% in 2023.
  • Biggest five-year swings in Operating Margin: surged 1036bps in 2021 and later tumbled -900bps in 2023.
  • Year by year, Operating Margin stood at 20.74% in 2021, then crashed by -38bps to 12.92% in 2022, then soared by 35bps to 17.38% in 2023, then increased by 0bps to 17.41% in 2024, then rose by 13bps to 19.64% in 2025.
  • Business Quant data shows Operating Margin for ABT at 19.64% in Q4 2025, 18.09% in Q3 2025, and 18.42% in Q2 2025.